PET/CT scanning to guide treatment for stomach cancer with abdominal spread
Part of Cancer, Digestive system clinical trials.
This trial uses two types of PET/CT scans (FDG and FAPI) to see how well chemotherapy or other treatments work before surgery for stomach cancer that has spread to the lining of the abdomen. The goal is to find the best way to measure treatment response and help guide your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have gastric adenocarcinoma (a type of stomach cancer) that has not been removed by surgery.
- The cancer must have spread to the lining of your abdomen (peritoneum), confirmed by a scope test, and you cannot have a blocked stomach or intestines.
- You must be 18 years or older and able to take care of most daily activities.
- You must have enough healthy organ and bone marrow function, and be expected to live at least 3 months.
- You cannot have other cancers or distant spread beyond the abdomen, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This study looks at images from two types of scans (a PET/CT and an MRI) taken of people with stomach cancer. It aims to see how well these scans work together to show the cancer, which could guide better treatment planning.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
This study tests whether a special PET scan can better show how well chemotherapy given directly into the abdomen is working, compared to standard scans. This may help doctors see changes in tumors earlier and guide treatment.
This trial uses CT scan images and a look inside the abdomen (laparoscopy) to predict whether advanced stomach cancer has spread to the lining of the abdomen (the peritoneum). It may help your care team better identify who already has peritoneal spread and who might not.
Hear when a new Peritoneal Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.